Persistent concerns that Alphabet Inc. has fallen behind in the artificial intelligence supremacy race has weighed on the ...

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...

NVIDIA will be the first industry partner to adopt SynthID, a Google DeepMind AI technology that embeds digital watermarks ...

Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...

Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...

AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...

U.S. tech titans Apple (AAPL) and Alphabet (GOOGL) are reportedly among other major names in talks with Japanese ...

Isomorphic Labs is raising money in its first-ever external funding round from Thrive Capital, a big backer of ChatGPT developer OpenAI ...

Houlihan Financial Resource Group Ltd. decreased its position in Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 2.2% during ...